Retraction: ‘MicroRNA-198 Inhibits Proliferation and Induces Apoptosis of Lung Cancer Cells Via Targeting FGFR1’(J Cell Biochem., (2014), 115, (5), (987-95), 10.1002/jcb.24742);MicroRNA-198 inhibits proliferation and induces apoptosis of lung cancer cells via targeting FGFR1

Journal of Cellular Biochemistry

Volumn 115, Issue 5, 2014, Pages 987-995

  Yang, Jun ^a   Zhao, Heng ^a   Xin, Yu ^a   Fan, Limin ^a  

^a SHANGHAI CHEST HOSPITAL   (China)

Author keywords

APOPTOSIS; FGFR1; LUNG CARCINOGENESIS; miR 198; VIABILITY

Indexed keywords

FIBROBLAST GROWTH FACTOR RECEPTOR 1; MICRORNA; MICRORNA 198; UNCLASSIFIED DRUG;

3' UNTRANSLATED REGION; ANIMAL EXPERIMENT; ANIMAL MODEL; APOPTOSIS; ARTICLE; BINDING SITE; CANCER CELL CULTURE; CANCER INHIBITION; CELL PROLIFERATION; CELL VIABILITY; CONTROLLED STUDY; FEMALE; GENE EXPRESSION; HUMAN; HUMAN CELL; LUNG CANCER; LUNG CARCINOGENESIS; MOUSE; NONHUMAN; OVERALL SURVIVAL; PHENOTYPE; PRIORITY JOURNAL; PROTEIN FUNCTION;

APOPTOSIS; FGFR1; LUNG CARCINOGENESIS; MIR-198; VIABILITY;

ANIMALS; APOPTOSIS; CARCINOMA, NON-SMALL-CELL LUNG; CELL LINE, TUMOR; CELL PROLIFERATION; GENE EXPRESSION REGULATION, NEOPLASTIC; HUMANS; LUNG NEOPLASMS; MICE; MICRORNAS; RECEPTOR, FIBROBLAST GROWTH FACTOR, TYPE 1; SIGNAL TRANSDUCTION; XENOGRAFT MODEL ANTITUMOR ASSAYS;

EID: 84895546941     PISSN: 07302312     EISSN: 10974644     Source Type: Journal    
DOI: 10.1002/jcb.30547     Document Type: Erratum

References (28)

1. Acevedo VD, Gangula RD, Freeman KW, Li R, Zhang Y, Wang F, Ayala GE, Peterson LE, Ittmann M, Spencer DM,. 2007. Inducible FGFR-1 activation leads to irreversible prostate adenocarcinoma and an epithelial-to-mesenchymal transition. Cancer Cell 12: 559-571.
2. Díaz-García CV, Agudo-Lõpez A, Pérez C, Lõpez-Martín JA, Rodríguez-Peralto JL, de Castro J, Cortijo A, Martínez-Villanueva M, Iglesias L, García-Carbonero R, Fresno Vara JA, Gámez-Pozo A, Palacios J, Cortés-Funes H, Paz-Ares L, Agullõ-Ortuño MT,. 2013. DICER1, DROSHA and miRNAs in patients with non-small cell lung cancer: Implications for outcomes and histologic classification. Carcinogenesis 34: 1031-1038.
3. Ebert MS, Neilson JR, Sharp PA,. 2007. MicroRNA sponges: Competitive inhibitors of small RNAs in mammalian cells. Nat Methods 4: 721-726.
4. Edwards J, Krishna NS, Witton CJ, Bartlett JM,. 2003. Gene amplifications associated with the development of hormone-resistant prostate cancer. Clin Cancer Res 9: 5271-5281.
5. Elfimova N, Sievers E, Eischeid H, Kwiecinski M, Noetel A, Hunt H, Becker D, Frommolt P, Quasdorff M, Steffen HM, Nürnberg P, Büttner R, Teufel A, Dienes HP, Drebber U, Odenthal M,. 2013. Control of mitogenic and motogenic pathways by miR-198, diminishing hepatoma cell growth and migration. Biochim Biophys Acta 1833: 1190-1198.
6. Farazi TA, Spitzer JI, Morozov P, Tuschl T,. 2011. miRNAs in human cancer. J Pathol 223: 102-115.
7. Farazi TA, Hoell JI, Morozov P, Tuschl T,. 2013. MicroRNAs in human cancer. Adv Exp Med Biol 774: 1-20.
8. Gorringe KL, Jacobs S, Thompson ER, Sridhar A, Qiu W, Choong DY, Campbell IG,. 2007. High-resolution single nucleotide polymorphism array analysis of epithelial ovarian cancer reveals numerous microdeletions and amplifications. Clin Cancer Res 13: 4731-4739.
9. Han HS, Yun J, Lim SN, Han JH, Lee KH, Kim ST, Kang MH, Son SM, Lee YM, Choi SY, Yun SJ, Kim WJ, Lee OJ,. 2013. Downregulation of cell-free miR-198 as a diagnostic biomarker for lung adenocarcinoma-associated malignant pleural effusion. Int J Cancer 133: 645-652.
10. Heist RS, Mino-Kenudson M, Sequist LV, Tammireddy S, Morrissey L, Christiani DC, Engelman JA, Iafrate AJ,. 2012. FGFR1 amplification in squamous cell carcinoma of the lung. J Thorac Oncol 7: 1775-1780.
11. Ihsan R, Chauhan PS, Mishra AK, Yadav DS, Kaushal M, Sharma JD, Zomawia E, Verma Y, Kapur S, Saxena S,. 2011. Multiple analytical approaches reveal distinct gene-environment interactions in smokers and non smokers in lung cancer. PLoS ONE 6: e29431.
12. Iorio MV, Croce CM,. 2009. MicroRNAs in cancer: Small molecules with a huge impact. J Clin Oncol 27: 5848-5856.
13. Ishizuka T, Tanabe C, Sakamoto H, Aoyagi K, Maekawa M, Matsukura N,. 2002. Gene amplification profiling of esophageal squamous cell carcinomas by DNA array CGH. Biochem Biophys Res Commun 296: 152-155.
14. Marshall AL, Christiani DC,. 2013. Genetic susceptibility to lung cancer-Light at the end of the tunnel Carcinogenesis 34: 487-502.
15. Rossi S, Di Narzo AF, Mestdagh P, Jacobs B, Bosman FT, Gustavsson B, Majoie B, Roth A, Vandesompele J, Rigoutsos I, Delorenzi M, Tejpar S,. 2012. microRNAs in colon cancer: a roadmap for discovery. FEBS Lett 586: 3000-3007.
16. Rothschild SI, Gautschi O,. 2013. Crizotinib in the treatment of non-small-cell lung cancer. Clin Lung Cancer 14: 473-480.
17. Schee K, Lorenz S, Worren MM, Günther CC, Holden M, Hovig E, Fodstad O, Meza-Zepeda LA, Flatmark K,. 2013. Deep sequencing the MicroRNA transcriptome in colorectal cancer. PLoS ONE 8: e66165.
18. Shen J, DiCioccio R, Odunsi K, Lele SB, Zhao H,. 2010. Novel genetic variants in miR-191 gene and familial ovarian cancer. BMC Cancer 10: 47.
19. Singh D, Chan JM, Zoppoli P, Niola F, Sullivan R, Castano A, Liu EM, Reichel J, Porrati P, Pellegatta S, Qiu K, Gao Z, Ceccarelli M, Riccardi R, Brat DJ, Guha A, Aldape K, Golfinos JG, Zagzag D, Mikkelsen T, Finocchiaro G, Lasorella A, Rabadan R, Iavarone A,. 2012. Transforming fusions of FGFR and TACC genes in human glioblastoma. Science 337: 1231-11235.
20. Tan S, Li R, Ding K, Lobie PE, Zhu T,. 2011. miR-198 inhibits migration and invasion of hepatocellular carcinoma cells by targeting the HGF/c-MET pathway. FEBS Lett 585: 2229-2234.
21. Varnholt H,. 2008. The role of microRNAs in primary liver cancer. Ann Hepatol 7: 104-113.
22. Vora N, Reckamp KL,. 2008. Non-small cell lung cancer in the elderly: Defining treatment options. Semin Oncol 35: 590-596.
23. Weir BA, Woo MS, Getz G, Perner S, Ding L, Beroukhim R,. 2007. Characterizing the cancer genome in lung adenocarcinoma. Nature 450: 893-898.
24. Wen D, Li S, Ji F, Cao H, Jiang W, Zhu J, Fang X,. 2013. miR-133b acts as a tumor suppressor and negatively regulates FGFR1 in gastric cancer. Tumour Biol 34: 793-803.
25. Xian W, Schwertfeger KL, Vargo-Gogola T, Rosen JM,. 2005. Pleiotropic effects of FGFR1 on cell proliferation, survival, and migration in a 3D mammary epithelial cell model. J Cell Biol 171: 663-673.
26. Yanaihara N, Caplen N, Bowman E, Seike M, Kumamoto K, Yi M, Stephens RM, Okamoto A, Yokota J, Tanaka T, Calin GA, Liu CG, Croce CM, Harris CC,. 2006. Unique microRNA molecular profiles in lung cancer diagnosis and prognosis. Cancer Cell 9: 189-198.
27. Yates LA, Norbury CJ, Gilbert RJ,. 2013. The long and short of microRNA. Cell 153: 516-519.
28. Ye L, Li S, Ye D, Yang D, Yue F, Guo Y, Chen X, Chen F, Zhang J, Song X,. 2013. Livin expression may be regulated by miR-198 in human prostate cancer cell lines. Eur J Cancer 49: 734-740.